Onalabs Inno-hub
The future of biomonitoring.
Cerdanyola del Vallès, Spain · Founded 2016 · $9.8M raised
- Headquarters
- Cerdanyola del Vallès
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- onalabs.com
- Total Funding
- $9.8M
- Last Round
- $6.4M GrantOct 2023
- Rounds
- 4
About
Onalabs Inno-Hub is a Barcelona-based biotech company developing Point-of-Care wearable biosensing technologies for continuous, non-invasive health monitoring. Their flagship product ONASPORT captures key biomarkers in sweat — including hydration, electrolytes, glucose, and inferred lactate thresholds — enabling real-time physiological insights without blood draws. The company addresses patients across all ages, from neonates with congenital heart disease to elderly patients with chronic heart failure and lung diseases. Onalabs has collaborated with Garmin Health, exhibited at MWC Barcelona and ATTD, and is part of the Barça Innovation Hub ecosystem.
Summary
Onalabs Inno-hub is a Healthcare company based in Cerdanyola del Vallès, Spain, founded in 2016. It has raised $9.8M in total across 4 rounds, most recently a $6.4M Grant round in Oct 2023. Investors include European Innovation Council Fund and LvlUp Ventures.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2023
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...